Pan Cancer T is an immunotherapy company developing next-generation TCR-T cell therapies for solid cancer, focused on exploiting specific targets on tumor cells.
investor of
Metrics
marketPRIVATE
msh_idCOM:PANCANCER-T
localede
websitehttps://pancancer-t.com/
source_ref31812a25-68ad-4aaf-9383-c9d9338f6acf
products_or_servicesNext-generation TCR-T cell therapies for solid tumors.
Germany